{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:01:03Z","timestamp":1746849663074,"version":"3.40.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["21181116","3220486","1221033"],"award-info":[{"award-number":["21181116","3220486","1221033"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competitive fund 2019 of the Chilean Society of Otorhinolaryngology and Head and Neck Surgery"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-024-00609-z","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:02:34Z","timestamp":1727431354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["cIAP-2 protein is upregulated by human papillomavirus in oropharyngeal cancers: role in radioresistance in vitro"],"prefix":"10.1186","volume":"19","author":[{"given":"Carolina","family":"Oliva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Carrillo-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Gallegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Mancilla-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Boettiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"609_CR1","unstructured":"zur Hausen, H. Human papillomavirus & cervical cancer. Indian J Med Res 2009, 130 209."},{"issue":"2","key":"609_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H Zur Hausen","year":"2009","unstructured":"Zur Hausen H. Papillomaviruses in the causation of human cancers\u2014a brief historical account. Virology. 2009;384(2):260\u20135.","journal-title":"Virology"},{"key":"609_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716.","journal-title":"Int J Cancer"},{"key":"609_CR4","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.canep.2022.102140","volume":"78","author":"Y Lu","year":"2022","unstructured":"Lu Y, Xie Z, Luo G, Yan H, Qian HZ, Fu L, Wang B, Huang R, Cao F, Lin H, et al. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region. Cancer Epidemiol. 2022;78:102140. https:\/\/doi.org\/10.1016\/j.canep.2022.102140.","journal-title":"Cancer Epidemiol"},{"key":"609_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11061060","author":"G Milano","year":"2023","unstructured":"Milano G, Guarducci G, Nante N, Montomoli E, Manini I. Human papillomavirus epidemiology and prevention: Is there still a gender gap? Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11061060.","journal-title":"Vaccines (Basel)"},{"key":"609_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky045","author":"S de Sanjos\u00e9","year":"2018","unstructured":"de Sanjos\u00e9 S, Serrano B, Tous S, Alejo M, Lloveras B, Quir\u00f3s B, Clavero O, Vidal A, Ferr\u00e1ndiz-Pulido C, Pav\u00f3n M, et al. Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58. JNCI Cancer Spectrum. 2018. https:\/\/doi.org\/10.1093\/jncics\/pky045.","journal-title":"JNCI Cancer Spectrum"},{"key":"609_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2016.08.001","volume":"772","author":"S Mittal","year":"2017","unstructured":"Mittal S, Banks L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutat Res Rev Mutat Res. 2017;772:23\u201335. https:\/\/doi.org\/10.1016\/j.mrrev.2016.08.001.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"609_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","volume":"98","author":"M Narisawa-Saito","year":"2007","unstructured":"Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98:1505\u201311. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00546.x.","journal-title":"Cancer Sci"},{"key":"609_CR9","doi-asserted-by":"publisher","first-page":"200213","DOI":"10.1016\/j.tvr.2021.200213","volume":"11","author":"A Vats","year":"2021","unstructured":"Vats A, Trejo-Cerro O, Thomas M, Banks L. Human papillomavirus E6 and E7: What remains? Tumour Virus Res. 2021;11:200213. https:\/\/doi.org\/10.1016\/j.tvr.2021.200213.","journal-title":"Tumour Virus Res"},{"key":"609_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","volume":"26","author":"K Hoppe-Seyler","year":"2018","unstructured":"Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6\/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26:158\u201368. https:\/\/doi.org\/10.1016\/j.tim.2017.07.007.","journal-title":"Trends Microbiol"},{"key":"609_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.virol.2008.02.025","volume":"375","author":"X Liu","year":"2008","unstructured":"Liu X, Roberts J, Dakic A, Zhang Y, Schlegel R. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. Virology. 2008;375:611\u201323. https:\/\/doi.org\/10.1016\/j.virol.2008.02.025.","journal-title":"Virology"},{"key":"609_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.virol.2016.02.015","volume":"492","author":"J Hochmann","year":"2016","unstructured":"Hochmann J, Sobrinho JS, Villa LL, Sichero L. The Asian-American variant of human papillomavirus type 16 exhibits higher activation of MAPK and PI3K\/AKT signaling pathways, transformation, migration and invasion of primary human keratinocytes. Virology. 2016;492:145\u201354. https:\/\/doi.org\/10.1016\/j.virol.2016.02.015.","journal-title":"Virology"},{"key":"609_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050672","author":"F Aguayo","year":"2023","unstructured":"Aguayo F, Perez-Dominguez F, Osorio JC, Oliva C, Calaf GM. PI3K\/AKT\/mTOR signaling pathway in HPV-driven head and neck carcinogenesis: therapeutic implications. Biology (Basel). 2023. https:\/\/doi.org\/10.3390\/biology12050672.","journal-title":"Biology (Basel)"},{"key":"609_CR14","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1038\/sj.onc.1207442","volume":"23","author":"E Toussaint-Smith","year":"2004","unstructured":"Toussaint-Smith E, Donner DB, Roman A. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene. 2004;23:2988\u201395. https:\/\/doi.org\/10.1038\/sj.onc.1207442.","journal-title":"Oncogene"},{"key":"609_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbrc.2013.04.060","volume":"435","author":"YS Jung","year":"2013","unstructured":"Jung YS, Kato I, Kim HR. A novel function of HPV16-E6\/E7 in epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2013;435:339\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.060.","journal-title":"Biochem Biophys Res Commun"},{"key":"609_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41419-023-05916-8","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang R, Wang Y, Liu X, Liu M, Sun L, Pan X, Hu H, Jiang B, Zou Y, Liu Q, et al. Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2\/NF\u03baB signaling. Cell Death Dis. 2023;14:388. https:\/\/doi.org\/10.1038\/s41419-023-05916-8.","journal-title":"Cell Death Dis"},{"key":"609_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/cas.13236","volume":"108","author":"X Jiang","year":"2017","unstructured":"Jiang X, Li C, Lin B, Hong H, Jiang L, Zhu S, Wang X, Tang N, Li X, She F, et al. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-\u03baB pathway. Cancer Sci. 2017;108:1144\u201356. https:\/\/doi.org\/10.1111\/cas.13236.","journal-title":"Cancer Sci"},{"key":"609_CR18","doi-asserted-by":"publisher","first-page":"118867","DOI":"10.1016\/j.lfs.2020.118867","volume":"266","author":"XJ Jiang","year":"2021","unstructured":"Jiang XJ, Chen ZW, Zhao JF, Liao CX, Cai QH, Lin J. cIAP2 via NF-\u03baB signalling affects cell proliferation and invasion in hepatocellular carcinoma. Life Sci. 2021;266:118867. https:\/\/doi.org\/10.1016\/j.lfs.2020.118867.","journal-title":"Life Sci"},{"key":"609_CR19","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.170111","author":"D Carrillo","year":"2017","unstructured":"Carrillo D, Mu\u00f1oz JP, Huerta H, Leal G, Corval\u00e1n A, Le\u00f3n O, Calaf GM, Urz\u00faa U, Boccardo E, Tapia JC, et al. Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells. Open Biol. 2017. https:\/\/doi.org\/10.1098\/rsob.170111.","journal-title":"Open Biol"},{"key":"609_CR20","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.7314\/apjcp.2012.13.11.5363","volume":"13","author":"EY Zhang","year":"2012","unstructured":"Zhang EY, Tang XD. Human papillomavirus type 16\/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pac J Cancer Prev. 2012;13:5363\u20139. https:\/\/doi.org\/10.7314\/apjcp.2012.13.11.5363.","journal-title":"Asian Pac J Cancer Prev"},{"key":"609_CR21","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1158\/1078-0432.CCR-10-0020","volume":"16","author":"HH Wu","year":"2010","unstructured":"Wu HH, Wu JY, Cheng YW, Chen CY, Lee MC, Goan YG, Lee H. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor\/phosphatidylinositol 3-kinase\/AKT pathway confers resistance to cisplatin in human papillomavirus 16\/18-infected lung cancer. Clin Cancer Res. 2010;16:5200\u201310. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0020.","journal-title":"Clin Cancer Res"},{"key":"609_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2407-10-118","volume":"10","author":"T Mitsuishi","year":"2010","unstructured":"Mitsuishi T, Iwabu Y, Tokunaga K, Sata T, Kaneko T, Ohara K, Ohsawa I, Oda F, Yamada Y, Kawana S, et al. Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors. BMC Cancer. 2010;10:118. https:\/\/doi.org\/10.1186\/1471-2407-10-118.","journal-title":"BMC Cancer"},{"key":"609_CR23","doi-asserted-by":"publisher","first-page":"154653","DOI":"10.1016\/j.prp.2023.154653","volume":"248","author":"ZMS Haghighi","year":"2023","unstructured":"Haghighi ZMS, Tabatabaei T, Rafigh M, Karampour R, Babaei F, Amjad ZS, Payandeh M, Roozgari M, Bayat M, Doroudian M, et al. Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer. Pathol Res Pract. 2023;248:154653. https:\/\/doi.org\/10.1016\/j.prp.2023.154653.","journal-title":"Pathol Res Pract"},{"key":"609_CR24","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/sj.onc.1208691","volume":"24","author":"H Yuan","year":"2005","unstructured":"Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen IS, Liu X. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene. 2005;24:5069\u201378. https:\/\/doi.org\/10.1038\/sj.onc.1208691.","journal-title":"Oncogene"},{"key":"609_CR25","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1128\/JVI.01942-05","volume":"80","author":"MA James","year":"2006","unstructured":"James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol. 2006;80:5301\u20137. https:\/\/doi.org\/10.1128\/JVI.01942-05.","journal-title":"J Virol"},{"key":"609_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13402-018-0403-7","volume":"42","author":"M Mikulandra","year":"2019","unstructured":"Mikulandra M, Kobescak A, Verillaud B, Busson P, Matijevic Glavan T. Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2. Cell Oncol (Dordr). 2019;42:29\u201340. https:\/\/doi.org\/10.1007\/s13402-018-0403-7.","journal-title":"Cell Oncol (Dordr)"},{"key":"609_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.radonc.2015.05.017","volume":"116","author":"O Matzinger","year":"2015","unstructured":"Matzinger O, Viertl D, Tsoutsou P, Kadi L, Rigotti S, Zanna C, Wiedemann N, Vozenin MC, Vuagniaux G, Bourhis J. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNF\u03b1-mediated in head and neck squamous cell carcinoma. Radiother Oncol. 2015;116:495\u2013503. https:\/\/doi.org\/10.1016\/j.radonc.2015.05.017.","journal-title":"Radiother Oncol"},{"key":"609_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/00016489.2016.1242776","volume":"137","author":"L Kadletz","year":"2017","unstructured":"Kadletz L, Enzenhofer E, Kotowski U, Altorjai G, Heiduschka G. AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation. Acta Otolaryngol. 2017;137:320\u20135. https:\/\/doi.org\/10.1080\/00016489.2016.1242776.","journal-title":"Acta Otolaryngol"},{"key":"609_CR29","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1002\/cam4.6011","volume":"12","author":"V Kansal","year":"2023","unstructured":"Kansal V, Kinney BLC, Uppada S, Saba NF, Stokes WA, Buchwald ZS, Schmitt NC. The expanding role of IAP antagonists for the treatment of head and neck cancer. Cancer Med. 2023;12:13958\u201365. https:\/\/doi.org\/10.1002\/cam4.6011.","journal-title":"Cancer Med"},{"key":"609_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/v14061212","author":"C Oliva","year":"2022","unstructured":"Oliva C, Carrillo-Beltr\u00e1n D, Boettiger P, Gallegos I, Aguayo F. Human papillomavirus detected in oropharyngeal cancers from chilean subjects. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14061212.","journal-title":"Viruses"},{"key":"609_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071904","author":"D Carrillo-Beltr\u00e1n","year":"2020","unstructured":"Carrillo-Beltr\u00e1n D, Mu\u00f1oz JP, Guerrero-V\u00e1squez N, Blanco R, Le\u00f3n O, de Souza Lino V, Tapia JC, Maldonado E, Dubois-Camacho K, Hermoso MA, et al. Human papillomavirus 16 E7 promotes EGFR\/PI3K\/AKT1\/NRF2 signaling pathway contributing to PIR\/NF-\u03baB activation in oral cancer cells. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12071904.","journal-title":"Cancers (Basel)"},{"key":"609_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/jnci\/djad169","volume":"115","author":"ZS Zumsteg","year":"2023","unstructured":"Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Lu DJ, Chen MM, Chaturvedi AK, et al. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023;115:1544\u201354. https:\/\/doi.org\/10.1093\/jnci\/djad169.","journal-title":"J Natl Cancer Inst"},{"key":"609_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164080","author":"S Ndon","year":"2023","unstructured":"Ndon S, Singh A, Ha PK, Aswani J, Chan JY, Xu MJ. Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15164080.","journal-title":"Cancers (Basel)"},{"key":"609_CR34","doi-asserted-by":"publisher","first-page":"djv403","DOI":"10.1093\/jnci\/djv403","volume":"108","author":"X Castellsagu\u00e9","year":"2016","unstructured":"Castellsagu\u00e9 X, Alemany L, Quer M, Halec G, Quir\u00f3s B, Tous S, Clavero O, Al\u00f2s L, Biegner T, Szafarowski T, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108:djv403. https:\/\/doi.org\/10.1093\/jnci\/djv403.","journal-title":"J Natl Cancer Inst"},{"key":"609_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-017-0484-y","author":"SH Huang","year":"2017","unstructured":"Huang SH, O\u2019Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017. https:\/\/doi.org\/10.1007\/s11864-017-0484-y.","journal-title":"Curr Treat Options Oncol"},{"key":"609_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24\u201335. https:\/\/doi.org\/10.1056\/NEJMoa0912217.","journal-title":"N Engl J Med"},{"key":"609_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pathol.2019.10.008","volume":"52","author":"EC Paver","year":"2020","unstructured":"Paver EC, Currie AM, Gupta R, Dahlstrom JE. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV. Pathology. 2020;52:179\u201391. https:\/\/doi.org\/10.1016\/j.pathol.2019.10.008.","journal-title":"Pathology"},{"key":"609_CR38","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","volume":"75","author":"M Nees","year":"2001","unstructured":"Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol. 2001;75:4283\u201396. https:\/\/doi.org\/10.1128\/JVI.75.9.4283-4296.2001.","journal-title":"J Virol"},{"key":"609_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/viro.2002.1468","volume":"298","author":"L Havard","year":"2002","unstructured":"Havard L, Delvenne P, Frar\u00e9 P, Boniver J, Giannini SL. Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. Virology. 2002;298:271\u201385. https:\/\/doi.org\/10.1006\/viro.2002.1468.","journal-title":"Virology"},{"key":"609_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.virol.2004.10.030","volume":"331","author":"L Havard","year":"2005","unstructured":"Havard L, Rahmouni S, Boniver J, Delvenne P. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology. 2005;331:357\u201366. https:\/\/doi.org\/10.1016\/j.virol.2004.10.030.","journal-title":"Virology"},{"key":"609_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/1871520622666220509180606","volume":"23","author":"N Garcia-Becerra","year":"2023","unstructured":"Garcia-Becerra N, Aguilar-Lemarroy A, Jave-Su\u00e1rez LF. On the regulation of NF-\u03baB pathway by HPV oncoproteins: Are pathway inhibitors a good alternative for the treatment of cervical cancer? Anticancer Agents Med Chem. 2023;23:492\u20137. https:\/\/doi.org\/10.2174\/1871520622666220509180606.","journal-title":"Anticancer Agents Med Chem"},{"key":"609_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ccr.2008.10.007","volume":"14","author":"J An","year":"2008","unstructured":"An J, Mo D, Liu H, Veena MS, Srivatsan ES, Massoumi R, Rettig MB. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell. 2008;14:394\u2013407. https:\/\/doi.org\/10.1016\/j.ccr.2008.10.007.","journal-title":"Cancer Cell"},{"key":"609_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"SC Sun","year":"2010","unstructured":"Sun SC. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ. 2010;17:25\u201334. https:\/\/doi.org\/10.1038\/cdd.2009.43.","journal-title":"Cell Death Differ"},{"key":"609_CR44","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1128\/JVI.00538-10","volume":"84","author":"M Xu","year":"2010","unstructured":"Xu M, Katzenellenbogen RA, Grandori C, Galloway DA. NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity. J Virol. 2010;84:11461\u20139. https:\/\/doi.org\/10.1128\/JVI.00538-10.","journal-title":"J Virol"},{"key":"609_CR45","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-\u03baB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition. J Cell Physiol. 2022;237:2770\u201395. https:\/\/doi.org\/10.1002\/jcp.30759.","journal-title":"J Cell Physiol"},{"key":"609_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbcan.2010.01.002","volume":"1805","author":"F Li","year":"2010","unstructured":"Li F, Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta. 2010;1805:167\u201380. https:\/\/doi.org\/10.1016\/j.bbcan.2010.01.002.","journal-title":"Biochim Biophys Acta"},{"key":"609_CR47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","volume":"14","author":"AR Kreimer","year":"2005","unstructured":"Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467\u201375. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0551.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"609_CR48","first-page":"200","volume":"34","author":"MC de Almagro","year":"2012","unstructured":"de Almagro MC, Vucic D. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol. 2012;34:200\u201311.","journal-title":"Exp Oncol"},{"key":"609_CR49","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1158\/1078-0432.CCR-18-3802","volume":"25","author":"R Xiao","year":"2019","unstructured":"Xiao R, An Y, Ye W, Derakhshan A, Cheng H, Yang X, Allen C, Chen Z, Schmitt NC, Van Waes C. Dual antagonist of cIAP\/XIAP ASTX660 sensitizes HPV. Clin Cancer Res. 2019;25:6463\u201374. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3802.","journal-title":"Clin Cancer Res"},{"key":"609_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041029","author":"T Toni","year":"2023","unstructured":"Toni T, Viswanathan R, Robbins Y, Gunti S, Yang X, Huynh A, Cheng H, Sowers AL, Mitchell JB, Allen CT, et al. Combined inhibition of IAPs and WEE1 enhances TNF\u03b1- and radiation-induced cell death in head and neck squamous carcinoma. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15041029.","journal-title":"Cancers (Basel)"},{"key":"609_CR51","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S1470-2045(17)30250-4","volume":"18","author":"R Mes\u00eda","year":"2017","unstructured":"Mes\u00eda R, Taberna M. HPV-related oropharyngeal carcinoma de-escalation protocols. Lancet Oncol. 2017;18:704\u20135. https:\/\/doi.org\/10.1016\/S1470-2045(17)30250-4.","journal-title":"Lancet Oncol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-024-00609-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-024-00609-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:02:57Z","timestamp":1746763377000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-024-00609-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1186\/s13027-024-00609-z","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliation assignment for all authors has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}